HomeWebcastA Practical Post-Alice Guidance: Effective Measures in Addressing Patent Eligibility Issues
Online CLE Patent Eligibility CLE

A Practical Post-Alice Guidance: Effective Measures in Addressing Patent Eligibility Issues

Live Webcast Date: Wednesday, November 13, 2019 from 3:00 pm to 5:00 pm (ET)
Intellectual Property Law (CLE)Live Webcast
Listen Live/On-Demand
Add to Calendar 11/13/2019 3:00 pm 11/13/2019 5:00 pm America/New_York The Knowledge Group Webinar: A Practical Post-Alice Guidance: Effective Measures in Addressing Patent Eligibility Issues If you haven’t registered for this event please click here:https://www.theknowledgegroup.org/checkout/?add-to-cart=113831\r\n In the wake of the U.S. Supreme Court decision in Alice Corp. v. CLS Bank International, the United States Patent and Trademark Office (USPTO) recently released a revised guidance for subject matter eligibility under 35 U.S.C. § 101. The new guidance, which intends “to improve the clarity, consistency and predictability of actions across the USPTO", provides a list of abstract concepts to define what composes an abstract idea. Due to its more "pro-patent" tone, an increase in the approval rates of patent applications is expected. \n \nAs the patent landscape continues to evolve, the number of patent eligibility issues also increases. Thus, it becomes more substantial for companies and their counsel to keep themselves updated of the most recent guidance in the evaluation of patent eligibility. \n \nIn this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the most effective measures in addressing patent eligibility issues in light of the Alice decision. They will also go beyond the basics and provide a comprehensive discussion of the new guideline’s implications. \n \nKey issues that will be covered in this course are: \n \n \n USPTO’s Revised Guidance for Patent Eligibility: An Overview \n Implications of the Revised Patent Eligibility Guidance \n Recent Trends, Developments and Updates \n Identifying Red Flags \n Opportunities and Pitfalls \n Best Practices \n What Lies Ahead? \n \n https://www.theknowledgegroup.org/webcasts/practical-post-alice-guidance/

Online CLE Patent Eligibility

In the wake of the U.S. Supreme Court decision in Alice Corp. v. CLS Bank International, the United States Patent and Trademark Office (USPTO) recently released a revised guidance for subject matter eligibility under 35 U.S.C. § 101. The new guidance, which intends “to improve the clarity, consistency and predictability of actions across the USPTO", provides a list of abstract concepts to define what composes an abstract idea. Due to its more "pro-patent" tone, an increase in the approval rates of patent applications is expected.

As the patent landscape continues to evolve, the number of patent eligibility issues also increases. Thus, it becomes more substantial for companies and their counsel to keep themselves updated of the most recent guidance in the evaluation of patent eligibility.

In this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the most effective measures in addressing patent eligibility issues in light of the Alice decision. They will also go beyond the basics and provide a comprehensive discussion of the new guideline’s implications.

Key issues that will be covered in this course are:

  • USPTO’s Revised Guidance for Patent Eligibility: An Overview
  • Implications of the Revised Patent Eligibility Guidance
  • Recent Trends, Developments and Updates
  • Identifying Red Flags
  • Opportunities and Pitfalls
  • Best Practices
  • What Lies Ahead?

Agenda

Leslie Kushner, Counsel
Pearl Cohen Zedek Latzer Baratz LLP

Who Should Attend

  • Patent Owners
  • Patent Attorneys
  • Intellectual Property Lawyers
  • Patent Consultants
  • Patent Licensing Attorneys
  • Patent Litigators
  • Patent Agents
  • Private Companies

Online CLE Patent Eligibility

Leslie Kushner, Counsel
Pearl Cohen Zedek Latzer Baratz LLP

Online CLE Patent Eligibility

Online CLE Patent Eligibility

Leslie KushnerCounselPearl Cohen Zedek Latzer Baratz LLP

Leslie Kushner is Counsel in the Litigation Group at Pearl Cohen’s New York office. She is an experienced intellectual property attorney, with extensive background in life sciences, biotechnology, and biochemistry. Dr. Kushner utilizes her decades of experience as a biomedical research scientist to represent clients in complex patent (including Hatch-Waxman), trade secret, and contract litigation across various industries, focusing her practice on chemical, biotechnological, pharmaceutical, diagnostic and medical device matters. She also counsels clients on patent validity and freedom-to-operate, performs intellectual property due diligence investigations, and negotiates and drafts licensing, joint venture, and consulting agreements.

Dr. Kushner’s experience includes patent infringement litigation pertaining to pharmaceutical and biotechnological inventions, trade secret litigation pertaining to drug formulations and educational services, copyright litigation pertaining to the entertainment industry, and contract litigation pertaining to biotechnological methods and educational services. Dr. Kushner has provided professional opinions on small-molecule pharmaceuticals, antibodies, cytokines, oligonucleotides, siRNA, enzyme inhibitors, and automotive parts, and has performed due diligence analyses for firms in the pharmaceutical, biotechnological, food, and gaming industries.


Click Here to Read Additional Material

Online CLE Patent Eligibility

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   Live Webcast

Prerequisite:
   General knowledge of intellectual property laws

Course Code:
   148060

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credits:
    2.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Pearl Cohen Zedek Latzer Baratz (“Pearl Cohen”) is an international law firm with offices around the globe: New York, Boston, Los Angeles, Tel-Aviv, Haifa and London. Due to the firm's multi-jurisdictional presence, Pearl Cohen's practice leaders excel in cross-border hi-tech, commercial, corporate, tax, securities, and litigation work, while being recognized as #1 for intellectual property and patent capabilities. Our professionals constitute one global team that collaborates seamlessly to provide clients with fully integrated legal services, tailoring legal and professional solutions across practice areas and industries.

Pearl Cohen primarily represents innovation-driven enterprises, including Fortune 500 and small-cap emerging companies, startups and entrepreneurs, investors, academic institutions and government-related entities. The firm’s international team and global offices work together seamlessly to provide clients with integrated legal services, advising on U.S., Israeli, and European legal issues, alongside activities in Russia & CIS, Latin-America, Australia, China and Japan.

Website: https://pearlcohen.com/

Leslie Kushner is Counsel in the Litigation Group at Pearl Cohen’s New York office. She is an experienced intellectual property attorney, with extensive background in life sciences, biotechnology, and biochemistry. Dr. Kushner utilizes her decades of experience as a biomedical research scientist to represent clients in complex patent (including Hatch-Waxman), trade secret, and contract litigation across various industries, focusing her practice on chemical, biotechnological, pharmaceutical, diagnostic and medical device matters. She also counsels clients on patent validity and freedom-to-operate, performs intellectual property due diligence investigations, and negotiates and drafts licensing, joint venture, and consulting agreements.

Dr. Kushner’s experience includes patent infringement litigation pertaining to pharmaceutical and biotechnological inventions, trade secret litigation pertaining to drug formulations and educational services, copyright litigation pertaining to the entertainment industry, and contract litigation pertaining to biotechnological methods and educational services. Dr. Kushner has provided professional opinions on small-molecule pharmaceuticals, antibodies, cytokines, oligonucleotides, siRNA, enzyme inhibitors, and automotive parts, and has performed due diligence analyses for firms in the pharmaceutical, biotechnological, food, and gaming industries.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199